Amezquita Alexander
Known title: Chief Financial OfficerCIK: 0001721325
Associated companies
Transaction History
| HLF | ▼ Sell | Tax Withholding | 116 | $1K | 3/3/2024 | View on chart |
| HLF | ▼ Sell | Tax Withholding | 616 | $5K | 2/25/2024 | View on chart |
| HLF | ▼ Sell | Tax Withholding | 637 | $5K | 2/19/2024 | View on chart |
| HLF | ▼ Sell | Tax Withholding | 1,081 | $13K | 2/7/2024 | View on chart |
| HLF | ▲ Buy | Grant | 2,635 | $0 | 2/7/2024 | View on chart |
| HLF | ▼ Sell | Tax Withholding | 1,263 | $16K | 11/9/2023 | View on chart |
| HLF | ▲ Buy | Grant | 25,735 | $0 | 5/4/2023 | View on chart |
| HLF | ▼ Sell | Tax Withholding | 38 | $784 | 3/3/2023 | View on chart |
| HLF | ▼ Sell | Tax Withholding | 506 | $10K | 2/25/2023 | View on chart |
| HLF | ▼ Sell | Tax Withholding | 1,457 | $30K | 2/20/2023 | View on chart |
| HLF | ▼ Sell | Tax Withholding | 211 | $4K | 2/19/2023 | View on chart |
| HLF | ▲ Buy | Grant | 94,637 | $0 | 12/9/2022 | View on chart |
| HLF | ▼ Sell | Tax Withholding | 421 | $7K | 11/9/2022 | View on chart |
| HLF | ▼ Sell | Tax Withholding | 38 | $1K | 3/3/2022 | View on chart |
| HLF | ▲ Buy | Grant | 7,507 | $0 | 2/25/2022 | View on chart |
| HLF | ▼ Sell | Tax Withholding | 840 | $36K | 2/21/2022 | View on chart |
| HLF | ▼ Sell | Tax Withholding | 498 | $22K | 2/20/2022 | View on chart |
| HLF | ▼ Sell | Tax Withholding | 207 | $9K | 2/19/2022 | View on chart |
| HLF | ▼ Sell | Tax Withholding | 421 | $18K | 11/9/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
HLF Featured in Mixed Stock Lists Amid High RSI
Recent articles from Yahoo and Benzinga discuss Herbalife in the context of long-term holdings and risk-off strategies, with one piece specifically citing reasons to avoid the stock. These mixed opinions appear while the stock trades near its 52-week high, reflecting a divergence between current price action and some analyst views. The news highlights ongoing debate over the company's value proposition among investors.
HLF Featured in Mixed Stock Lists Amid High RSI. Recent articles from Yahoo and Benzinga discuss Herbalife in the context of long-term holdings and risk-off strategies, with one piece specifically citing reasons to avoid the stock. These mixed opinions appear while the stock trades near its 52-week high, reflecting a divergence between current price action and some analyst views. The news highlights ongoing debate over the company's value proposition among investors.